Background: As Alzheimer's disease (AD) and cerebral small vessel disease (CSVD)
commonly coexist, the interaction between two has been of the considerable interest …

Objective To evaluate the association between brain amyloid β (Aβ) and cerebral small
vessel disease (CSVD) markers, as well as their joint effect on cognition, in a memory clinic …

Background Cerebrovascular disease (CVD) and amyloid-β (Aβ) often coexist, but their
influence on neurodegeneration and cognition in predementia stages remains unclear. We …

Objective: To determine the independent and synergistic effects of amyloid and small vessel
disease (SVD) burden on longitudinal cognitive decline in patients with subcortical vascular …

INTRODUCTION We assessed whether co‐morbid small vessel disease (SVD) has clinical
predictive value in preclinical or prodromal Alzheimer's disease. METHODS In 1090 non …

Objective This study investigated cerebral small vessel disease (CSVD) damage patterns in
early‐onset and late‐onset Alzheimer's disease (EOAD and LOAD) and their effects on …

Background Research suggests that cerebral small vessel disease (CSVD), amyloid, and
pTau contribute to age-related cognitive decline. It remains unknown how these factors …

Cognitive impairment includes mild cognitive decline and dementia, such as Alzheimer's
disease (AD) and cerebrovascular-related pathologies. Objective: To investigate the profile …

Alzheimer's disease (AD) is characterized by the presence of β-amyloid (Aβ) and tau, and
subcortical vascular cognitive impairment (SVCI) is characterized by cerebral small vessel …

Alzheimer disease (AD) and sporadic cerebral small vessel disease (CSVD) are common
cognitive disorders. Both AD and CSVD have mental symptoms including chronic …